# The Role of Ghrelin in Cancer Cachexia

> **NCT01505764** · PHASE2 · TERMINATED · sponsor: **VA Office of Research and Development** · enrollment: 10 (actual)

## Conditions studied

- Cancer Cachexia

## Interventions

- **DRUG:** Anamorelin HCl
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01505764
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2016-01
- **Final completion:** 2016-03
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** poor recruitment
- **Last updated:** 2018-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01505764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01505764, "The Role of Ghrelin in Cancer Cachexia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01505764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*